VERA THERAPEUTICS INC
NASDAQ: VERA (Vera Therapeutics, Inc.)
Last update: 4 hours ago33.60
-0.18 (-0.53%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Vera Therapeutics, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 3.97% |
| % Held by Institutions | 112.39% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Jun 2026 | 5,723,888 |
| Deep Track Capital, Lp | 30 Jun 2026 | 4,000,000 |
| Kynam Capital Management, Lp | 30 Jun 2026 | 2,890,059 |
| Sofinnova Investments, Inc. | 30 Jun 2026 | 2,793,987 |
| Eversept Partners, Lp | 30 Jun 2026 | 2,212,770 |
| Integral Health Asset Management, Llc | 30 Jun 2026 | 1,750,000 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FORDYCE MARSHALL | - | 35.66 | -18,500 | -659,710 |
| Aggregate Net Quantity | -18,500 | |||
| Aggregate Net Value ($) | -659,710 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 35.66 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FORDYCE MARSHALL | Officer | 02 Sep 2026 | Automatic sell (-) | 18,500 | 35.66 | 659,710 |
| FORDYCE MARSHALL | Officer | 02 Sep 2026 | Option execute | 18,500 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |